Matches in SemOpenAlex for { <https://semopenalex.org/work/W2186457922> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2186457922 abstract "Objective: To determine the principal adverse effects of the tuberculosis treatment regimen recommended by the Brazilian Ministry of Health. Methods: A prospective descriptive study involving 79 tuberculosis patients treated at the Clinical Research Center of the Cassiano Antonio Moraes University Hospital, in the city of Vitoria, Brazil, between 2003 and 2006. The treatment regimen consisted of isoniazid, rifampicin, pyrazinamide and ethambutol for four months, followed by rifampicin and isoniazid for two months. During the treatment period, the patients were clinically evaluated every week and had a monthly medical visit. Results: The overall incidence of adverse effects was 83.54%. Articular/bone/muscle involvement was the most common, followed by skin involvement (24.94% and 22.09%, respectively). Adverse effects were more common in the second month of treatment (41.59%). Modification of the treatment regimen was unnecessary. One patient required concomitant medication to counter the adverse effects. The cure rate was 100%. Conclusions: The overall incidence of adverse effects related to the new treatment regimen recommended by the Brazilian Ministry of Health was high. However, none of those effects demanded a change in the regimen, which was effective in the patients evaluated." @default.
- W2186457922 created "2016-06-24" @default.
- W2186457922 creator A5001587791 @default.
- W2186457922 creator A5001628510 @default.
- W2186457922 creator A5015859831 @default.
- W2186457922 creator A5019494972 @default.
- W2186457922 creator A5033212843 @default.
- W2186457922 creator A5050639074 @default.
- W2186457922 creator A5068589038 @default.
- W2186457922 creator A5080713014 @default.
- W2186457922 date "2010-01-01" @default.
- W2186457922 modified "2023-09-27" @default.
- W2186457922 title "Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian National Ministry of Health* Efeitos adversos causados pelo novo esquema de tratamento da tuberculose preconizado pelo Ministério da Saúde do Brasil" @default.
- W2186457922 cites W113327459 @default.
- W2186457922 cites W135253615 @default.
- W2186457922 cites W1982515608 @default.
- W2186457922 cites W1989219811 @default.
- W2186457922 cites W1989527043 @default.
- W2186457922 cites W1992121986 @default.
- W2186457922 cites W2049496729 @default.
- W2186457922 cites W2062243603 @default.
- W2186457922 cites W2077687108 @default.
- W2186457922 cites W2109028417 @default.
- W2186457922 cites W2110149852 @default.
- W2186457922 cites W2141859976 @default.
- W2186457922 cites W2154396724 @default.
- W2186457922 cites W2169831776 @default.
- W2186457922 cites W2422498755 @default.
- W2186457922 hasPublicationYear "2010" @default.
- W2186457922 type Work @default.
- W2186457922 sameAs 2186457922 @default.
- W2186457922 citedByCount "0" @default.
- W2186457922 crossrefType "journal-article" @default.
- W2186457922 hasAuthorship W2186457922A5001587791 @default.
- W2186457922 hasAuthorship W2186457922A5001628510 @default.
- W2186457922 hasAuthorship W2186457922A5015859831 @default.
- W2186457922 hasAuthorship W2186457922A5019494972 @default.
- W2186457922 hasAuthorship W2186457922A5033212843 @default.
- W2186457922 hasAuthorship W2186457922A5050639074 @default.
- W2186457922 hasAuthorship W2186457922A5068589038 @default.
- W2186457922 hasAuthorship W2186457922A5080713014 @default.
- W2186457922 hasConcept C120665830 @default.
- W2186457922 hasConcept C121332964 @default.
- W2186457922 hasConcept C126322002 @default.
- W2186457922 hasConcept C138885662 @default.
- W2186457922 hasConcept C141071460 @default.
- W2186457922 hasConcept C142724271 @default.
- W2186457922 hasConcept C197934379 @default.
- W2186457922 hasConcept C27206212 @default.
- W2186457922 hasConcept C2776228421 @default.
- W2186457922 hasConcept C2776967927 @default.
- W2186457922 hasConcept C2778607973 @default.
- W2186457922 hasConcept C2780459521 @default.
- W2186457922 hasConcept C2781069245 @default.
- W2186457922 hasConcept C2781413609 @default.
- W2186457922 hasConcept C521751864 @default.
- W2186457922 hasConcept C61511704 @default.
- W2186457922 hasConcept C71924100 @default.
- W2186457922 hasConceptScore W2186457922C120665830 @default.
- W2186457922 hasConceptScore W2186457922C121332964 @default.
- W2186457922 hasConceptScore W2186457922C126322002 @default.
- W2186457922 hasConceptScore W2186457922C138885662 @default.
- W2186457922 hasConceptScore W2186457922C141071460 @default.
- W2186457922 hasConceptScore W2186457922C142724271 @default.
- W2186457922 hasConceptScore W2186457922C197934379 @default.
- W2186457922 hasConceptScore W2186457922C27206212 @default.
- W2186457922 hasConceptScore W2186457922C2776228421 @default.
- W2186457922 hasConceptScore W2186457922C2776967927 @default.
- W2186457922 hasConceptScore W2186457922C2778607973 @default.
- W2186457922 hasConceptScore W2186457922C2780459521 @default.
- W2186457922 hasConceptScore W2186457922C2781069245 @default.
- W2186457922 hasConceptScore W2186457922C2781413609 @default.
- W2186457922 hasConceptScore W2186457922C521751864 @default.
- W2186457922 hasConceptScore W2186457922C61511704 @default.
- W2186457922 hasConceptScore W2186457922C71924100 @default.
- W2186457922 hasLocation W21864579221 @default.
- W2186457922 hasOpenAccess W2186457922 @default.
- W2186457922 hasPrimaryLocation W21864579221 @default.
- W2186457922 isParatext "false" @default.
- W2186457922 isRetracted "false" @default.
- W2186457922 magId "2186457922" @default.
- W2186457922 workType "article" @default.